Bahram Valamehr, Chief R&D Officer: Fate Therapeutics FATE Sell · Filed 23/01/11

Trade details

Type: Insider sale
Amount: $57,205.08
Shares · price: 10,917 sh · $5.24 a share
Held after: 168,917 sh
Stock: Fate Therapeutics FATE
Person: Bahram ValamehrChief R&D Officer
Trade date: 23/01/10
Filed: 23/01/11
Days to filing: 1 days

Sold 6.1% of holdings

Share of holding sold: 6.1%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/11~23/02/09

Bahram Valamehr's recent trades

Bahram ValamehrPresident and CEO
Planned saleFate Therapeutics
Planned sale
Fate Therapeutics
FATE
$108.1K
43,947 sh
$108.1K
Filed 08/04
Traded 08/04
Bahram ValamehrPresident and CEO
SellFate Therapeutics
Sell
Fate Therapeutics
FATE
$54.4K
28,946 sh
$54.4K
Filed 05/21
Traded 05/20
Bahram ValamehrPresident and CEO
Planned saleFate Therapeutics
Planned sale
Fate Therapeutics
FATE
$54.5K
28,946 sh
$54.5K
Filed 05/20
Traded 05/20
Bahram ValamehrPresident and CEO
SellFate Therapeutics
Sell
Fate Therapeutics
FATE
$5,553
5,190 sh
$5,553
Filed 01/12
Traded 01/09
Bahram ValamehrPresident and CEO
Planned saleFate Therapeutics
Planned sale
Fate Therapeutics
FATE
$5,557
5,190 sh
$5,557
Filed 01/09
Traded 01/09